Sofinnova Investments’s Jade Biosciences JBIO Stock Holding History

Sofinnova Investments’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.51M	Hold	107,391	–	–	0.06%	67
2025 Q4	$1.66M	Hold	107,391	–	–	0.07%	57
2025 Q3	$927K	Hold	107,391	–	–	0.05%	57
2025 Q2	$1.07M	Hold	107,391	–	–	0.07%	55
2025 Q1	$9.43M	Hold	107,391	–	–	0.62%	39
2024 Q4	$9.96M	Hold	107,391	–	–	0.73%	33
2024 Q3	$7.86M	Hold	107,391	–	–	0.62%	34
2024 Q2	$6.24M	Hold	107,391	–	–	0.32%	54
2024 Q1	$111M	Hold	107,391	–	–	6.19%	4
2023 Q4	$85.1M	Hold	107,391	–	–	4.76%	6
2023 Q3	$51M	Hold	107,391	–	–	3.22%	8
2023 Q2	$64.5M	Hold	107,391	–	–	4.22%	6
2023 Q1	$75.8M	Hold	107,391	–	–	4.85%	6
2022 Q4	$110M	Hold	107,391	–	–	6.54%	3
2022 Q3	$62.3M	Hold	107,391	–	–	3.63%	5
2022 Q2	$58.7M	Hold	107,391	–	–	4.89%	4
2022 Q1	$68.9M	Hold	107,391	–	–	5.23%	5
2021 Q4	$44.3M	Hold	107,391	–	–	2.59%	7
2021 Q3	$78.9M	Hold	107,391	–	–	4.67%	4
2021 Q2	$85.8M	Buy	+107,391	New	+$85.8M	4.95%	3

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sofinnova Investments's JBIO Position: Q1 2026 in Review

Sofinnova Investments held its Jade Biosciences (JBIO) position steady in Q1 2026 at 107,391 shares worth $1.51M. The position accounts for 0.06% of the portfolio, ranked #67.

Sofinnova Investments first reported a position in JBIO in Q2 2021 and has held it in 20 quarters since. The position peaked at $111M in Q1 2024. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

Sofinnova Investments held 107,391 shares of Jade Biosciences worth $1.51M as of Q1 2026.
Sofinnova Investments left its Jade Biosciences share count unchanged in Q1 2026.
Jade Biosciences made up 0.06% of Sofinnova Investments's portfolio in Q1 2026, its #67 holding.
Sofinnova Investments first reported a position in Jade Biosciences in Q2 2021 and has held it in 20 quarters since.
Sofinnova Investments's Jade Biosciences position peaked at $111M in Q1 2024.
120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.